COVID-19-Related Audit Report Disclosures: Determinants and Consequences
Abstract
:1. Introduction
2. Institutional Knowledge and Hypothesis Development
2.1. Institutional Knowledge
2.1.1. COVID-19 General Information
2.1.2. COVID-19 Public Healthcare and Economics Research
2.1.3. The Impact of COVID-19 Uncertainty on Firms and Auditors—General
2.1.4. The Impact of COVID-19 Uncertainty on Firms and Auditors—Accounting Perspective
“Now with the updated U.S. GAAP and U.S. generally accepted auditing standards requirements, entities have to make a going concern assessment based upon whether it’s probable that they will be unable to meet their obligations within one year from the issuance of the financial statements, not the balance sheet date. The increased difficulty caused by the longer period is compounded by the uncertainty arising from the unprecedented nature of the pandemic and its recession”.
2.1.5. Critical Audit Matters (CAMs)
2.2. Hypothesis Development
3. Research Design and Sample
3.1. COVID-19 Reports
3.2. Data and Sample
3.2.1. Research Design
3.2.2. Endogeneity
4. Empirical Results
5. Sensitivity Analyses and Discussion
5.1. Entropy Balancing
5.2. General COVID-19 Risk and Endogeneity
5.3. Instrumental Variable Approach
5.4. Untabulated Results
5.5. Discussion
6. Conclusions
Author Contributions
Funding
Institutional Review Board Statement
Informed Consent Statement
Data Availability Statement
Conflicts of Interest
Appendix A. Variable Definitions
Variable | Definition | Source |
Key Variables | ||
COVID REPORT | An indicator variable equal to one when the firm’s audit report mentions COVID-19, and 0 otherwise. | Auditor Reports |
COVID REPORT—IMPAIRMENT | An indicator variable equal to one if the firm’s audit report mentions COVID-19 and that citation relates to an asset impairment assessment. | Auditor Reports |
COVID REPORT—FV | An indicator variable equal to one if the firm’s audit report mentions COVID-19 and that citation related to a fair value accounting issue. | Auditor Reports |
COVID REPORT—GCO | An indicator variable equal to one if the firm’s audit report mentions COVID-19 and that citation related to a going concern issue. | Auditor Reports |
ACCT ESTIMATE | An indicator variable equal to one if an audit report relates to an accounting estimate and zero otherwise. | Auditor Reports |
SIG ACCT ESTIMATE | A discrete, ordinal variable equal to 2 if the audit report mentions a significant accounting estimate, 1 if the audit report relates to an accounting estimate with low estimation on certainty, and zero otherwise. | Auditor Reports |
COVID-RISK | A firm-level measure of exposure to epidemic diseases including COVID-19, SARS, and H1N1 as calculated in Hassan et al. (2023) | Hassan et al. (2023) |
COVID_RESIDUAL | The Residual from the equation: COVID REPORTit = β0 + β1COVID-RISKit + λiIndustry-FE + ε | Audit Reports/Hassan et al. (2023) |
COVID CASES | The logarithm transformation of the rolling 6-month average number of cases for the county in which a firm is headquartered. | NYT COVID-19 Data |
The predicted value of the dependent variable from the equation: COVID REPORTit = β0 + β1COVID CASESit + λiIndustry-FE + µiState-FE + ε | NYT COVID-19 Data | |
AUDIT FEES | The natural logarithmic transformation of audit fees for firm i in fiscal year t. | Audit Analytics |
ABNORMAL AF | Abnormal audit fees as calculated by Blankley et al. (2012). | Blankley et al. (2012) |
Control Variables | ||
ADVERTISING | Calculated as the firm’s advertising costs (XAD) scaled by total assets (AT). | Compustat |
AMEX | An indicator variable equal to one if the firm is traded in the American Stock Exchange, and 0 otherwise. | CRSP |
AP | Calculated as the firm’s accounts payable (AP) scaled by total assets (AT). | Compustat |
AR | Calculated as the firm’s accounts receivables (RECT) scaled by total assets (AT). | Compustat |
AUD OFFICE SIZE | Calculated as the audit firm’s office yearly audit fees scaled by total yearly audit fees for the audit market. | Audit Analytics |
BIG4 | An indicator variable equal to one if the firm engaged a Big4 auditor during the fiscal year, and 0 otherwise. | Audit Analytics |
BUSY | An indicator variable equal to one if the firm’s fiscal year end is in December of January, and 0 otherwise. | Compustat |
CAPEX | Calculated as the firm’s capital expenditures (CAPX) scaled by total assets (AT). | Compustat |
CASH | Calculated as the firm’s cash and cash equivalents (CHE) scaled by total assets (AT). | Compustat |
CASH FLOWS | Calculated as the firm’s cash flows from operating expenses (OANCF) scaled by total assets (AT). | Compustat |
CLIENT IMPORT | Calculated as the sum of the client’s audit fees and non-audit fees scaled by total yearly audit fees for the auditor. | Audit Analytics |
COS | Calculated as the firm’s cost of sales (COGS) scaled by total assets (AT). | Compustat |
COMMON STOCK | Calculated as the firm’s common stock (CEQ) scaled by total assets (AT). | Compustat |
DEBT | Calculated as the sum of firm’s short-term (DLC) and long-term debt (DLTT) scaled by total assets (AT). | Compustat |
DEFERRED REV | Calculated as the sum of firm’s short-term (DRC) and long-term deferred revenue (DRLT) scaled by total assets (AT). | Compustat |
DIVIDENDS | Calculated as the firm’s dividends (DVC) scaled by total assets (AT). | Compustat |
FOREIGN | An indicator variable equal to 1 if firm i has any foreign operations, and 0 otherwise. | Compustat |
GOODWILL | Calculated as the firm’s goodwill (GDWL) scaled by total assets (AT). | Compustat |
INTANGIBLE | Calculated as the firm’s intangible assets (INTAN) excluding goodwill (GDWL) scaled by total assets (AT). | Compustat |
INVENTORY | Calculated as the firm’s inventory (INVT) scaled by total assets (AT). | Compustat |
LN NAF | The natural logarithmic transformation of non-audit fees for firm i in fiscal year t. | Audit Analytics |
MCAP | Calculated as the firms stock price at fiscal year end (PRC) multiplied by number of shares outstanding at fiscal year end (SHROUT). | CRSP |
MTB | Calculated as market capitalization of equity (MCAP) scaled by the book value of common equity (CEQ). | Compustat/CRSP |
MW | An indicator variable equal to 1 if the client receives a material weakness opinion in the current year or the next year and 0 otherwise. | Audit Analytics |
NASDAQ | An indicator variable equal to one if the firm is traded in the NASDAQ Stock Exchange, and 0 otherwise. | CRSP |
NET INCOME | Calculated as the firm’s income before extraordinary items (IB) scaled by total assets (AT). | Compustat |
NYSE | An indicator variable equal to one if the firm is traded in the New York Stock Exchange, and 0 otherwise. | CRSP |
POS_RETURNS | An indicator variable equal to one if the firm has a total postivie Cumulative Abnormal Return (CAR) during the (-3,3) day window. | CRSP |
PPE | Calculated as the firm’s net property, plant, and equipment (PPENT) scaled by total assets (AT). | Compustat |
R&D | Calculated as the firm’s research and development costs (XRD) scaled by total assets (AT). | Compustat |
RESTATEMENT | An indicator variable equal to 1 if the firm receives a financial statement restatement during fiscal year t, and 0 otherwise. | Audit Analytics |
RETAINED EARNINGS | Calculated as the firm’s retained earnings (RE) scaled by total assets (AT). | Compustat |
REVENUES | Calculated as the firm’s revenues (REV) scaled by total assets (AT). | Compustat |
SEGMENTS | Calculated as the logarithm of the number of business segments. | Compustat |
SGA | Calculated as the firm’s selling, general, and administrative (XSGA) scaled by total assets (AT). | Compustat |
SIZE | Calculated as the logarithmic transformation of total assets (AT). | Compustat |
SPECIALIST | An indicator variable equal to one if the auditor is the current market leader in the client firm’s SIC2 digit industry during the year of the audit, and 0 otherwise. | Audit Analytics |
SPI | Calculated as the firm’s special items (SPI) scaled by total assets (AT). | Compustat |
TENURE | The number of years of the current client-auditor relationship. | Audit Analytics |
Z-SCORE | The likelihood of bankruptcy calculated per Altman (1968). | Altman (1968) |
Appendix B. Examples of COVID-19 Audit Reports by Accounting Topic
Appendix B.1. Panel A: Audit Report Example—Fair Value Accounting
Appendix B.2. Panel B: Audit Report Example—Going Concern Opinion
Appendix B.3. Panel C: Audit Report Example—Historical Cost Accounting
Appendix C. Accounting and Significant Accounting Estimates Detailed by Topic Issue
Low Accounting Estimates | Significant Accounting Estimates |
Allowance for Doubtful Accounts | Acquisitions/Business Combinations |
Depreciation Expense | Contingent Liabilities |
Non-impairment related Fair Value Measurement | Financial Derivatives |
Inventory Obsolescence | Going Concern/Liquidity Concerns |
Minor Litigation | Goodwill |
Nonmonetary Exchange | Intangible Assets |
Retirement Benefits | Investments |
Securities Valuation | Provision for Loan Losses |
Valuation | Revenue Recognition |
Warranties | Share/Stock-Based Compensation |
Tax Uncertainty |
1 | See Bauer et al. (2021) for a review of research questions covering the potential impacts of the COVID-19 pandemic on auditors’ group judgment and decision making (JDM). |
2 | They find that the use of these public health measures reduced disease transmission in the short run and produced better economic outcomes in the medium run. |
3 | |
4 | After investigating all CAMS, we note that the first reference to Covid-19 in the audit report occurs in December 2019. We note that if we begin the sample during this time, our results are consistent without the approximate ~700 observations reported from July through November. |
5 | Appendix C outlines the accounting and significant accounting estimates detailed by topic issue. |
6 | Results are largely similar if we defined industry specialization as the proportion of the auditor’s market share in the SIC2 digit industry based on audit fees. |
7 | The lambda in Equation (1) refers to the vector of beta coefficients, which from tautology in the auditing literature are omitted in the presentation of the results. |
8 | To assess this marginal effect we refer to the relatively simplistic division rule of Gelman and Hill (2007). |
9 | For brevity, we exclude the CONSTANT CUT 1, CONSTANT CUT 2, and CONSTANT CUT 3 variables, which represent the multiple constants generated as part of the ordered probit model. |
10 | We utilize all available daily returns data during this period and require 3 consecutive days of trading, which reduces the sample size, but results are consistent if we don’t utilize this restriction. |
11 | Cumulative abnormal returns are then calculated by summing the β0 for each time t over the relevant window. |
12 | Due to sample size limitations for some financial performance metrics such as restatements and GCOs, we are not able to effectively test the statistical significance of these in regression models. |
13 | This amount is calculated as the 17.2% of logged audit fees: EXP(0.172) – 1. |
14 | This economic magnitude is calculated as 0.172 * $2,627,108 mean audit fees for the sample, rounded to the nearest thousand dollars. |
15 | Results are also consistent if we only entropy balance in the key determinants of receiving a COVID REPORT: INTANGIBLE, GOODWILL, and BIG4. |
16 | See Table 3, Panel A and Panel B for descriptive statistics around the reweighting of covariates before and after entropy balancing. |
17 | Using the number of COVID-19 and other epidemic risks mentioned in firms’ quarterly earnings conference call and other textual classifications, Hassan et al. (2023) measure firms’ specific risk to epidemics and the channel through which these risks occur (e.g., supply and demand impacts, costs reductions, etc.). |
18 | In untabulated results, we note that when we reperform the main tests of our paper, Hassan et al. “Covid Risk” measure is not statistically related to receiving any auditor disclosure in the audit report, but it is a predictor of receiving a COVID-19 audit report. |
19 | This data can be downloaded via the NYT’s GitHub page: https://github.com/nytimes/covid-19-data (accessed on 25 December 2024). |
20 | We utilize a 6-month rolling average (as opposed to a 12-month) in order to have sufficient data for firms with audit reports dated from September 2020 through February 2021. The NYT only began collecting data as of March 2020 so a restriction of 12-months of data would reduce our testing sample nearly in half. Results are qualitately and oftern times quantitatively significant after the reduction in sample size if we were to require a full 12 motnhs of data. |
21 | Other important test statistics are those of the Durbin chi2 tests and Wu-Hausman F statistics, which demonstrate whether the dependent variable is endogenous. For example, the results of the first stage regression, when audit fees is used as the dependent variable for the 2nd stage regression, demonstrates that COVID CASES present a correlated instrument with COVID REPORT. |
22 | For example, when using audit fees as the dependent variable for the 2nd stage regression, the p-values of 0.04 and 0.00 for the Durbin chi2 test statistic and the Wu-Hausman F-statistic, respectively, indicate no endogenous regressors. |
23 | Note that the number of observations in these regressions are considerably lower than those in the main results as, by design, all observations in the pre-COVID era (NY Times data collection begins in March 2020) drop from the regression as do those observations for firms in counties with missing values of COVID-19 cases in the NYT data. |
24 | To fully understand these tests, it is important to highlight the necessary steps needed by management to assess whether long-term assets have been impaired. The FASB’s guidance in ASU 2017-04 Intangibles—Goodwill and Other (Topic 350), demonstrates that management must annually perform a qualitative assessment of asset impairment and if it is more likely than not that the fair value of the reporting unit in which the asset is maintained is less than the carrying value then managers need to perform a Step 2 quantitative assessment, where they actually calculate this fair value amount and check for impairment. |
References
- Altiga, D., Baker, S., Barrero, J. M., Bloom, N., Bunn, P., Chen, S., Davis, S. J., Leather, J., Meyer, B., Mihaylov, E., Mizen, P., Parker, N., Renault, T., Smietanka, P., & Thwaites, G. (2020). Economic uncertainty before and during the COVID-19 pandemic. Journal of Public Economics, 191, 104274. [Google Scholar] [CrossRef] [PubMed]
- Altman, E. I. (1968). Financial ratios, discriminant analysis and prediction of. The Journal of Finance, 23, 589–609. [Google Scholar] [CrossRef]
- American Institute of CPAs [AICPA]. (2003). Auditing fair value measurements and disclosures. A.U. Section 328. Available online: https://pcaobus.org/oversight/standards/archived-standards/pre-reorganized-auditing-standards-interpretations/details/AU328 (accessed on 25 September 2024).
- American Institute of CPAs [AICPA]. (2014). Guide to intangible asset valuation: Accounting and financial reporting (R. P. Schweihs, & R. F. Reilly, Eds.). American Institute of CPAs (AICPA). [Google Scholar]
- American Institute of CPAs [AICPA]. (2020). How to audit during a pandemic? You asked. We answered. AICPA Insights Blog. Available online: https://www.primeglobal.net/news/how-to-audit-during-a-pandemic-aicpa (accessed on 25 September 2024).
- Backof, A., Bowlin, K., & Goodson, B. (2014). The importance of clarification of auditors’ responsibilities under the new audit reporting standards. Contemporary Accounting Research, 39(4), 2284–2304. [Google Scholar] [CrossRef]
- Baker, S. R., Bloom, N., & Davis, S. J. (2016). Measuring economic policy uncertainty. The Quarterly Journal of Economics, 131(4), 1593–1636. [Google Scholar] [CrossRef]
- Barth, M. E., Konchitchki, Y., & Landsman, W. R. (2013). Cost of capital and earnings transparency. Journal of Accounting and Economics, 55, 206–224. [Google Scholar] [CrossRef]
- Bauer, T. D., Humphreys, K. A., & Trotman, K. T. (2021). Group judgment and decision making in auditing: Research in the time of COVID-19 and beyond. AUDITING: A Journal of Practice & Theory. forthcoming. [Google Scholar]
- Berglund, N. R. (2020). Do client bankruptcies preceded by clean audit opinions damage auditor reputation? Contemporary Accounting Research, 37(3), 1914–1951. [Google Scholar] [CrossRef]
- Blankley, A. I., Hurtt, D. N., & MacGregor, J. E. (2012). Abnormal audit fees and restatements. Auditing: A Journal of Practice & Theory, 31(1), 79–96. [Google Scholar]
- Bloomberg Law. (2022, March 31). Why supply chains are entering third year of chaos: Quick take. Available online: https://news.bloomberglaw.com/international-trade/why-supply-chains-are-entering-third-year-of-chaos-quicktake (accessed on 25 September 2024).
- Brasel, K., Doxey, M. M., Grenier, J. H., & Reffett, A. (2016). Risk disclosure preceding negative outcomes: The effects of reporting critical audit matters on judgments of auditor liability. The Accounting Review, 91(5), 1345–1362. [Google Scholar] [CrossRef]
- Bukhari, Q., & Jameel, Y. (2020). Will coronavirus pandemic diminish by summer? SSRN Working Paper. Available online: https://papers.ssrn.com/sol3/papers.cfm?abstract_id=3556998 (accessed on 25 September 2024).
- Burke, J. J., Hoitash, R., Hoitash, U., & Xiao, S. (2023). The disclosure and consequences of U.S. critical audit matters. The Accounting Review, 98(2), 59–095. [Google Scholar] [CrossRef]
- Caggiano, G., Castelnuovo, E., & Kima, R. (2020). The global effects of COVID-19-induced uncertainty. Economic Letters, 194, 109392. [Google Scholar] [CrossRef] [PubMed]
- Christensen, B. E., Glover, S. M., & Wolfe, C. J. (2014). Do critical audit matter paragraphs in the audit report change nonprofessional investors’ decision to invest? Auditing: A Journal of Practice & Theory, 33(4), 71–93. [Google Scholar]
- Correia, S., Luck, S., & Verner, E. (2020). Pandemics depress the economy, public health interventions do not: Evidence from the 1918 Flu. SSRN Working Paper. Available online: https://papers.ssrn.com/sol3/papers.cfm?abstract_id=3561560 (accessed on 25 September 2024).
- Cutler, D. M., & Summers, L. H. (2020). The COVID-19 pandemic and the $16 trillion virus. The Journal of the American Medical Association, 324(15), 1495–1496. [Google Scholar] [CrossRef]
- Deloitte. (2020). Financial reporting considerations related to COVID-19 and an economic downturn. Financial Reporting Alert 20-2. Deloitte. [Google Scholar]
- Disparte, D. (2021, February 16). Preparing for the next pandemic: Early lessons from COVID-19. Brookings Institution. Available online: https://www.brookings.edu/research/preparing-for-the-next-pandemic-early-lessons-from-covid-19/ (accessed on 15 May 2021).
- Doogar, R., Sivadasan, P., & Solomon, I. (2015). Audit fee residuals, costs or rents? Review of Accounting Studies, 20, 1247–1286. [Google Scholar] [CrossRef]
- Financial Accounting Standards Board [FASB]. (2014). Presentation of financial statements—Going concern (subtopic 205-40). Financial Accounting Standards Board (FASB). [Google Scholar]
- Francis, J. R., Michas, P. N., & Yu, M. (2013). Office size of Big 4 auditors and client restatements. Contemporary Accounting Research, 30(4), 1626–1661. [Google Scholar] [CrossRef]
- Garcíaa, S., Gambetta, N., García-Benauc, M. A., & Orta-Pérezd, M. (2019). Understanding the determinants of the magnitude of entity-level risk and account-level risk key audit matters: The case of the United Kingdom. The British Accounting Review, 51(3), 227–240. [Google Scholar] [CrossRef]
- Gelman, A., & Hill, J. (2007). Data analysis using regression and multilevel/hierarchical models (1st ed.). Cambridge University Press. [Google Scholar]
- Gimbar, C., Hansen, B., & Ozlanski, M. (2016). The effects of critical audit matter paragraphs and accounting standard precision on auditor liability. The Accounting Review. forthcoming. [Google Scholar] [CrossRef]
- Goncharov, I., Riedl, E. J., & Sellhorn, T. (2013). Fair value and audit fees. Review of Accounting Studies, 19, 210–241. [Google Scholar] [CrossRef]
- Greenstone, M., & Nigam, V. (2020). Does social distancing matter? University of Chicago Working Paper No. 2020-26. University of Chicago. [Google Scholar]
- Guo, F., Lisic, L. L., Pittman, J. A., Seidel, T. A., Zhou, M., & Zhou, Y. (2022). Fool me once, shame on you; fool me twice, shame on me, the impact of audit partners’ first-hand experience with arthur andersen’s demise on their style. Contemporary Accounting Research, 39(3), 1986–2022. [Google Scholar] [CrossRef]
- Hainmueller, J. (2012). Entropy balancing for causal effects: A multivariate reweighting method to produce balanced samples in observational studies. Political Analysis, 20, 25–46. [Google Scholar] [CrossRef]
- Harris, J. (2020). The coronavirus epidemic curve is already flattening in new york city. NBER Working Paper No. 26917. NBER. [Google Scholar]
- Hassan, T. A., Hollander, S., Lent, L. V., Schwedeler, M., & Tahoun, A. (2023). Firm-level exposure to epidemic diseases: COVID-19, SARS, and H1N1. The Review of Financial Studies, 36(12), 4919–4964. [Google Scholar] [CrossRef]
- Hong, H., Kubik, J. D., Wang, N., Xu, X., & Yang, J. (2021). Pandemics, vaccines and an earnings damage function. National Bureau of Economic Research Working Paper Number 27829. National Bureau of Economic Research. [Google Scholar]
- Hribar, P., Kravet, T., & Wilson, R. (2014). A new measure of accounting quality. Review of Accounting Studies, 19, 506–538. [Google Scholar] [CrossRef]
- Huikki, J., Mouritsen, J., & Silvola, H. (2017). Relative reliability and the recognisable firm: Calculating goodwill impairment value. Accounting, Organizations, and Society, 56, 68–83. [Google Scholar] [CrossRef]
- Johns Hopkins Coronavirus Resource Center. (2021, October 14). COVID-19 dashboard. Available online: https://www.scirp.org/reference/referencespapers?referenceid=3025590 (accessed on 1 December 2021).
- Johnson, R. N., & Wiley, L. D. (2019). Auditing: A practical approach with data analytics. John Wiley & Sons. [Google Scholar]
- Kachelmeier, S., Rimkus, D., Schmidt, J. J., & Valentine, K. (2020). The forewarning effect of critical audit matter disclosures involving measurement uncertainty. Contemporary Accounting Research, 37(4), 2186–2212. [Google Scholar] [CrossRef]
- Kim, S., & Klein, A. (2017). Did the 1999 NYSE and NASDAQ listing standard changes on audit committee composition benefit investors? The Accounting Review, 92(6), 187–212. [Google Scholar] [CrossRef]
- KPMG. (2019, December). Fair value measurement: questions and answers. Available online: https://assets.kpmg.com/content/dam/kpmg/be/pdf/2020/01/fair-value-qa-2019.pdf (accessed on 15 May 2021).
- KPMG. (2020, December 3). Are fair values appropriately determined and disclosed? What’s the issue? Available online: https://home.kpmg/xx/en/home/insights/2020/03/covid-19-assets-1b.html (accessed on 15 May 2021).
- Lawrence, A., Minutti-Meza, M., & Zhang, P. (2011). Can Big 4 versus non-Big 4 differences in audit-quality proxies be attributed to client characteristics? The Accounting Review, 86(1), 259–286. [Google Scholar] [CrossRef]
- McKibbin, W., & Fernando, R. (2020). The Global macroeconomic impacts of COVID-19: Seven scenarios. Centre for Applied Macroeconomic Analysis (CAMA) Working Paper. CAMA. [Google Scholar]
- Murphy, M. L. (2020, December). Assessing audit risks during the pandemic. Journal of Accountancy. Available online: https://www.journalofaccountancy.com/news/2020/dec/assess-audit-risks-during-coronavirus-pandemic.html (accessed on 12 May 2021).
- New York Times [NYT]. (2021a, December 5). How the supply chain crisis unfolded. Available online: https://www.nytimes.com/interactive/2021/12/05/business/economy/supply-chain.html (accessed on 15 April 2022).
- New York Times [NYT]. (2021b, October 14). Tracking coronavirus in new york: Latest map and case count. Available online: https://www.nytimes.com/interactive/2021/us/new-york-covid-cases.html (accessed on 15 April 2022).
- New York Times [NYT]. (2022a, April 25). COVID lockdowns revive the ghosts of a planned economy. Available online: https://www.nytimes.com/2022/04/25/business/china-covid-zero-economy.html (accessed on 21 May 2022).
- New York Times [NYT]. (2022b, May 16). One million deaths. Coronavirus briefing newsletter. Available online: https://www.nytimes.com/2022/05/16/briefing/one-million-deaths.html (accessed on 21 May 2022).
- Noll, D. (2020, December 14). 4 A&A challenges caused by COVID-19. AICPA. AICPA blog. Available online: https://nsacoop.org/articles/4-aa-challenges-caused-covid-19 (accessed on 15 May 2021).
- O’Keefe, T. B., Simunic, D. A., & Stein, M. T. (1994). The production of audit services, evidence from a major public accounting firm. Journal of Accounting Research, 32, 241–261. [Google Scholar] [CrossRef]
- Ozili, P., & Arun, T. (2020). Spillover of COVID-19: Impact on the global economy. SSRN Working Paper. Available online: https://papers.ssrn.com/sol3/papers.cfm?abstract_id=3562570 (accessed on 15 May 2021).
- Parmet, W. E., & Sinha, M. S. (2020). COVID-19—The Law and Limits of Quarantine. The New England Journal of Medicine, 382(e28), 1–3. [Google Scholar] [CrossRef]
- PCAOB. (2017). AS 3101. The auditor’s report on an audit of financial statements when the auditor expresses an unqualified opinion. PCAOB Release No. 2017-001. Washington, DC, USA. Available online: https://pcaobus.org/Rulemaking/Docket034/2017-001-auditors-report-final-rule.pdf (accessed on 17 December 2022).
- PCAOB. (2019, March 18). Implementation of critical audit matters: The basics. staff guidance. Washington, DC, USA. Available online: https://pcaobus.org/Standards/Documents/Implementation-of-Critical-Audit-Matters-The-Basics.pdf (accessed on 17 December 2022).
- Radigan, J. (2021). Pandemic still complicates going concern disclosures. Journal of Accountancy. Available online: https://www.journalofaccountancy.com/news/2021/jun/coronavirus-pandemic-complicates-going-concern-disclosures.html?utm_source=mnl:cpald&utm_medium=email&utm_campaign=15Jun2021 (accessed on 23 August 2021).
- Ramanna, K., & Watts, R. L. (2012). Evidence on the use of unverifiable estimates in required goodwill impairment. Review of Accounting Studies, 17, 749–780. [Google Scholar] [CrossRef]
- Sajadi, M. M., Habibzadeh, P., Vintzileos, A., Shokouhi, S., Miralles-Wilhelm, F., & Amoroso, A. (2020). Temperature, humidity, and latitude analysis to predict potential spread and seasonality for COVID-19. SSRN Working Paper. Available online: https://papers.ssrn.com/sol3/papers.cfm?abstract_id=3550308 (accessed on 23 August 2021).
- Siegel, R. (2021). What’s in Congress’s $1.9 trillion covid bill: Checks, unemployment insurance and more. The Washington Post. Available online: https://www.washingtonpost.com/business/2021/03/10/what-is-in-the-stimulus/ (accessed on 22 August 2021).
- Simunic, D. A. (1980). The pricing of audit services: Theory and evidence. Journal of Accounting Research, 18, 161–190. [Google Scholar] [CrossRef]
- Stein, S. (2019). Auditor industry specialization and accounting estimates: Evidence from asset impairments. Auditing: A Journal of Practice & Theory, 38(2), 207–234. [Google Scholar]
- Suljac, V. (2021). Litigation risk, financial reporting quality, and critical audit matters in the audit report: Early, U.S. evidence. SSRN Working Paper. Available online: https://papers.ssrn.com/sol3/papers.cfm?abstract_id=3771081 (accessed on 22 August 2021).
- Szczygielski, J. J., Bwanya, P. R., Charteris, A., & Brzeszczynski, J. (2021). The only certainty is uncertainty: An analysis of the impact of COVID-19 uncertainty on regional stock markets. Finance Research Letters. forthcoming. [Google Scholar] [CrossRef] [PubMed]
- Tysiac, K. (2021, December). PCAOB changes 2021 inspection focus areas as a result of COVID-19. Journal of Accountancy. Available online: https://www.journalofaccountancy.com/news/2020/dec/pcaob-changes-2021-inspection-focus-areas-result-of-coronavirus.html (accessed on 15 May 2022).
- Verrecchia, R. E. (1983). Discretionary disclosure. Journal of Accounting and Economics, 5, 179–194. [Google Scholar] [CrossRef]
Panel A: | |||
Full Sample | |||
Sample Filter | Firms | Firm Obs | |
1 | Compustat: 01/01/2018 to 05/31/2021 | 7553 | 21,389 |
2 | After merging with AuditAnalytics | 6199 | 16,926 |
3 | Limiting to the Critical Audit Matter (CAM) period Report Date: 06/30/2019 to 05/31/2021 | 5770 | 11,740 |
4 | After requiring non-missing values for covariates | 5651 | 11,498 |
5651 | 11,498 | ||
Panel B: | |||
Covid Audit Reports by Accounting Estimate Type | Firm Obs | ||
1 | Significant Accounting Estimates | 308 | |
2 | Low Estimation Uncertainty Accounting Estimates | 3 | |
3 | Not Accounting Estimates | 92 | |
Total Covid Audit Reports: | 403 | ||
Panel C: | |||
Covid Audit Reports by Accounting Topic | Firm Obs | ||
1 | Fair Value Accounting | 322 | |
2 | Going Concern / Emphasis of Matter Opinion | 63 | |
3 | Historical Cost Accounting | 18 | |
Total Covid Audit Reports: | 403 | ||
Panel D: | |||
SIC | Sample by SIC 1 digit industry | Firm Obs | Firm Percentage |
1 | Agriculture | 34 | 0.30% |
2 | Mining | 781 | 6.79% |
3 | Construction | 2534 | 22.04% |
4 | Manufacturing | 2089 | 18.17% |
5 | Transportation, Communications, Electric | 1023 | 8.90% |
6 | Wholesale | 599 | 5.21% |
7 | Retail | 2422 | 21.06% |
8 | Finance | 1495 | 13.00% |
9 | Services | 395 | 3.44% |
10 | Public Administration | 126 | 1.10% |
Total Covid Audit Reports: | 11,498 | 100% |
N | Mean | St.Dev | p25 | Median | p75 | |
---|---|---|---|---|---|---|
COVID REPORT | 11,498 | 0.035 | 0.184 | 0.000 | 0.000 | 0.000 |
ACCT ESTIMATE | 11,498 | 0.822 | 0.881 | 0.000 | 1.000 | 2.000 |
SIG ACCT ESTIMATE | 11,498 | 1.113 | 1.292 | 0.000 | 1.000 | 3.000 |
CASH | 11,498 | 0.247 | 0.283 | 0.039 | 0.120 | 0.360 |
AR | 11,498 | 0.158 | 0.207 | 0.023 | 0.082 | 0.186 |
INVENTORY | 11,498 | 0.057 | 0.101 | 0.000 | 0.005 | 0.077 |
PPE | 11,498 | 0.214 | 0.260 | 0.019 | 0.101 | 0.311 |
INTANGIBLE | 11,498 | 0.061 | 0.109 | 0.000 | 0.008 | 0.075 |
GOODWILL | 11,498 | 0.083 | 0.135 | 0.000 | 0.006 | 0.114 |
AP | 11,498 | 0.171 | 0.388 | 0.016 | 0.043 | 0.113 |
DEFERRED REV | 11,498 | 0.035 | 0.087 | 0.000 | 0.000 | 0.023 |
DEBT | 11,498 | 0.403 | 0.895 | 0.059 | 0.239 | 0.448 |
RETAINED EARNINGS | 11,498 | −4.639 | 22.256 | −0.968 | −0.029 | 0.130 |
DIVIDENDS | 11,498 | 0.010 | 0.025 | 0.000 | 0.000 | 0.009 |
COMMON STOCK | 11,498 | −0.029 | 2.519 | 0.127 | 0.369 | 0.605 |
REVENUES | 11,498 | 0.560 | 0.632 | 0.082 | 0.367 | 0.791 |
COS | 11,498 | 0.398 | 0.513 | 0.046 | 0.212 | 0.548 |
SGA | 11,498 | 0.347 | 0.903 | 0.014 | 0.105 | 0.319 |
R&D | 11,498 | 0.085 | 0.212 | 0.000 | 0.000 | 0.063 |
CAPEX | 11,498 | 0.028 | 0.042 | 0.002 | 0.012 | 0.036 |
ADVERTISING | 11,498 | 0.008 | 0.029 | 0.000 | 0.000 | 0.001 |
NET INCOME | 11,498 | −0.332 | 1.385 | −0.168 | 0.004 | 0.039 |
SPI | 11,498 | −0.021 | 0.097 | −0.011 | −0.000 | 0.000 |
CASH FLOWS | 11,498 | −0.128 | 0.644 | −0.074 | 0.032 | 0.093 |
TENURE | 11,498 | 6.156 | 6.010 | 2.000 | 4.000 | 8.000 |
BIG4 | 11,498 | 0.626 | 0.484 | 0.000 | 1.000 | 1.000 |
SPECIALIST | 11,498 | 0.155 | 0.362 | 0.000 | 0.000 | 0.000 |
Panel A: Determinants & Accounting Estimate Models | |||||||||||
Before Entropy Balancing | After Entropy Balancing | ||||||||||
COVID REPORT | NON-COVID REPORT | COVID REPORT | NON-COVID REPORT | ||||||||
N | Mean | N | Mean | Diff | t-Stat | Mean | Variance | Mean | Variance | ||
ACCT ESTIMATE | 403 | 1.650 | 11,095 | 0.791 | 0.859 | (19.55) | *** | ||||
SIG ACCT ESTIMATE | 403 | 2.414 | 11,095 | 1.066 | 1.349 | (20.95) | *** | ||||
CASH | 403 | 0.142 | 11,095 | 0.251 | −0.110 | (−7.65) | *** | 0.142 | 0.027 | 0.142 | 0.036 |
AR | 403 | 0.212 | 11,095 | 0.157 | 0.056 | (5.30) | *** | 0.212 | 0.061 | 0.212 | 0.064 |
INVENTORY | 403 | 0.057 | 11,095 | 0.058 | −0.001 | (−0.15) | 0.057 | 0.009 | 0.057 | 0.012 | |
PPE | 403 | 0.216 | 11,095 | 0.214 | 0.001 | (0.10) | * | 0.216 | 0.064 | 0.216 | 0.073 |
INTANGIBLE | 403 | 0.082 | 11,095 | 0.060 | 0.022 | (3.85) | *** | 0.082 | 0.016 | 0.082 | 0.020 |
GOODWILL | 403 | 0.107 | 11,095 | 0.083 | 0.024 | (3.50) | *** | 0.107 | 0.021 | 0.107 | 0.025 |
AP | 403 | 0.221 | 11,095 | 0.169 | 0.052 | (2.65) | *** | 0.221 | 0.171 | 0.221 | 91.72 |
DEFERRED REV | 403 | 0.026 | 11,095 | 0.036 | −0.010 | (−2.30) | ** | 0.026 | 0.004 | 0.026 | 0.005 |
DEBT | 403 | 0.482 | 11,095 | 0.400 | 0.083 | (1.80) | * | 0.482 | 0.603 | 0.482 | 1.006 |
RETAINED EARNINGS | 403 | −1.723 | 11,095 | −4.745 | 3.022 | (2.70) | *** | −1.723 | 126.1 | −1.723 | 79.83 |
DIVIDENDS | 403 | 0.008 | 11,095 | 0.011 | −0.003 | (−1.90) | * | 0.008 | 0.000 | 0.008 | 0.000 |
COMMON STOCK | 403 | 0.051 | 11,095 | −0.033 | 0.083 | (0.65) | 0.051 | 2.733 | 0.051 | 3.185 | |
REVENUES | 403 | 0.590 | 11,095 | 0.559 | 0.031 | (0.95) | 0.590 | 0.595 | 0.590 | 0.910 | |
COS | 403 | 0.422 | 11,095 | 0.397 | 0.025 | (0.95) | 0.422 | 0.456 | 0.422 | 0.761 | |
SGA | 403 | 0.176 | 11,095 | 0.353 | −0.177 | (−3.85) | *** | 0.176 | 0.191 | 0.176 | 0.094 |
R&D | 403 | 0.020 | 11,095 | 0.088 | −0.068 | (−6.25) | *** | 0.020 | 0.006 | 0.020 | 0.004 |
CAPEX | 403 | 0.019 | 11,095 | 0.028 | −0.009 | (−4.35) | *** | 0.019 | 0.001 | 0.019 | 0.001 |
ADVERTISING | 403 | 0.009 | 11,095 | 0.009 | −0.000 | (−0.00) | 0.009 | 0.001 | 0.009 | 0.003 | |
NET INCOME | 403 | −0.144 | 11,095 | −0.340 | 0.196 | (2.80) | *** | −0.144 | 0.503 | −0.144 | 0.378 |
SPI | 403 | −0.044 | 11,095 | −0.020 | −0.024 | (−4.90) | *** | −0.044 | 0.011 | −0.044 | 0.019 |
CASH FLOWS | 403 | −0.003 | 11,095 | −0.133 | 0.130 | (4.00) | *** | −0.003 | 0.082 | −0.003 | 0.056 |
TENURE | 403 | 6.250 | 11,095 | 6.152 | 0.099 | (0.30) | 6.250 | 43.13 | 6.250 | 40.15 | |
BIG4 | 403 | 0.553 | 11,095 | 0.629 | −0.075 | (−3.10) | *** | 0.553 | 0.245 | 0.553 | 0.247 |
SPECIALIST | 403 | 0.142 | 11,095 | 0.156 | −0.014 | (−0.75) | 0.142 | 0.122 | 0.142 | 0.121 | |
AUD OFFICE SIZE | 403 | 0.005 | 11,095 | 0.004 | 0.000 | (0.25) | 0.004 | 0.000 | 0.004 | 0.000 | |
Panel B: Audit Fees & Abnormal Audit Fees Models | |||||||||||
Before Entropy Balancing | After Entropy Balancing | ||||||||||
COVID REPORT | NON-COVID REPORT | COVID REPORT | NON-COVID REPORT | ||||||||
N | Mean | N | Mean | Diff | t-Stat | Mean | Variance | Mean | Variance | ||
AUDIT FEES | 403 | 14.09 | 11,095 | 13.65 | 0.431 | (5.49) | *** | ||||
ABNORMAL AF | 403 | 0.005 | 11,095 | −0.005 | −0.010 | (0.27) | |||||
SIZE | 403 | 7.347 | 11,095 | 6.411 | 0.940 | (6.25) | *** | 7.349 | 6.376 | 7.344 | 8.785 |
INVENTORY | 403 | 0.057 | 11,095 | 0.059 | −0.005 | (−0.35) | 0.057 | 0.009 | 0.057 | 0.012 | |
AR | 403 | 0.213 | 11,095 | 0.157 | 0.054 | (5.25) | *** | 0.213 | 0.061 | 0.212 | 0.065 |
NET INCOME | 403 | −0.187 | 11,095 | −2.483 | 2.29 | (−0.55) | −0.186 | 2.192 | −0.188 | 32.25 | |
R&D | 403 | 0.020 | 11,095 | 0.323 | −0.302 | (−0.50) | 0.020 | 0.006 | 0.021 | 0.004 | |
CAPEX | 403 | 0.019 | 11,095 | 0.035 | −0.016 | (−0.80) | 0.019 | 0.001 | 0.019 | 0.001 | |
DEBT | 403 | 0.483 | 11,095 | 0.482 | 0.001 | (−1.80) | * | 0.482 | 0.603 | 0.483 | 1.226 |
FOREIGN | 403 | 0.224 | 11,095 | 0.239 | −0.015 | (−0.70) | 0.223 | 0.174 | 0.223 | 0.173 | |
SEGMENTS | 403 | 1.960 | 11,095 | 1.496 | 0.465 | (6.00) | *** | 1.955 | 3.217 | 1.954 | 3.385 |
MW | 403 | 0.048 | 11,095 | 0.034 | 0.014 | (1.45) | 0.047 | 0.045 | 0.047 | 0.045 | |
RESTATEMENT | 403 | 0.007 | 11,095 | 0.084 | −0.076 | (−5.50) | *** | 0.007 | 0.007 | 0.007 | 0.007 |
BIG4 | 403 | 0.553 | 11,095 | 0.629 | −0.075 | (−3.10) | *** | 0.553 | 0.248 | 0.553 | 0.247 |
TENURE | 403 | 6.250 | 11,095 | 6.152 | 0.099 | (0.30) | *** | 6.345 | 43.13 | 6.343 | 39.04 |
SPECIALIST | 403 | 0.142 | 11,095 | 0.156 | −0.014 | (−0.75) | 0.141 | 0.122 | 0.141 | 0.121 | |
AUD OFFICE SIZE | 403 | 0.005 | 11,095 | 0.004 | 0.000 | (0.25) | 0.004 | 0.000 | 0.004 | 0.000 | |
LN NAF | 403 | 9.723 | 11,095 | 8.999 | 0.724 | (2.75) | *** | 9.723 | 25.60 | 9.719 | 26.31 |
CLIENT IMPORT | 403 | 0.231 | 11,095 | 0.258 | −0.026 | (−0.03) | 0.231 | 0.091 | 0.231 | 0.095 | |
BUSY | 403 | 0.859 | 11,095 | 0.830 | 0.029 | (0.02) | 0.859 | 0.122 | 0.859 | 0.121 |
(1) | (2) | |
---|---|---|
COVID REPORT | COVID REPORT | |
CASH | −0.006 | −0.007 |
(−0.52) | (−0.57) | |
AR | −0.005 | −0.008 |
(−0.33) | (−0.48) | |
INVENTORY | 0.008 | 0.003 |
(0.33) | (0.15) | |
PPE | 0.018 | 0.019 |
(1.37) | (1.45) | |
INTANGIBLE | 0.039 ** | 0.036 * |
(2.07) | (1.89) | |
GOODWILL | 0.037 ** | 0.044 ** |
(2.15) | (2.54) | |
AP | 0.000 | 0.000 |
(0.84) | (0.81) | |
DEFERRED REV | −0.002 | −0.003 |
(−0.39) | (−0.49) | |
DEBT | 0.000 | 0.000 |
(0.51) | (0.46) | |
RETAINED EARNINGS | 0.001 | 0.001 |
(0.34) | (0.38) | |
DIVIDENDS | −0.006 | −0.006 |
(−1.30) | (−1.28) | |
COMMON STOCK | 0.000 | 0.000 |
(0.47) | (0.42) | |
REVENUES | 0.003 | 0.003 |
(0.99) | (0.98) | |
COS | 0.000 | 0.000 |
(0.20) | (0.10) | |
SGA | 0.000 | 0.000 |
(0.21) | (0.21) | |
R&D | 0.000 | 0.000 |
(0.34) | (0.41) | |
CAPEX | −0.016 | −0.016 |
(−1.45) | (−1.48) | |
ADVERTISING | −0.012 | −0.011 |
(−0.57) | (−0.54) | |
NET INCOME | 0.000 | 0.000 |
(0.21) | (0.21) | |
SPI | 0.000 | 0.000 |
(0.18) | (0.20) | |
CASH FLOWS | 0.000 | 0.000 |
(0.28) | (0.42) | |
TENURE | −0.000 | |
(−0.25) | ||
BIG4 | −0.012 *** | |
(−2.83) | ||
SPECIALIST | 0.001 | |
(0.12) | ||
AUD OFFICE SIZE | 0.170 | |
(0.85) | ||
CONSTANT | 0.026 *** | 0.033 *** |
(2.90) | (3.53) | |
Observations | 11,498 | 11,498 |
Ind FE | YES | YES |
Pseudo R-squared | 0.019 | 0.019 |
(1) | (2) | |
---|---|---|
ACCT ESTIMATE | SIG ACCT ESTIMATE | |
COVID REPORT | 1.316 *** | 1.348 *** |
(14.41) | (18.73) | |
CASH | −0.533 *** | −0.777 *** |
(−5.69) | (−9.07) | |
AR | −0.480 *** | −0.401 *** |
(−3.97) | (−3.66) | |
INVENTORY | −0.812 *** | −0.935 *** |
(−4.42) | (−5.58) | |
PPE | 0.178 * | −0.144 |
(1.67) | (−1.50) | |
INTANGIBLE | −0.468 *** | −0.342 *** |
(−3.23) | (−2.61) | |
GOODWILL | 1.073 *** | 0.889 *** |
(8.13) | (7.61) | |
AP | 0.042 *** | 0.026 ** |
(4.00) | (2.12) | |
DEFERRED REV | −0.021 | −0.142 |
(−0.27) | (−1.45) | |
DEBT | 0.006 ** | 0.012 *** |
(1.97) | (3.05) | |
RETAINED EARNINGS | 0.703 ** | 0.320 |
(2.52) | (1.37) | |
DIVIDENDS | 0.004 | 0.010 |
(0.10) | (0.27) | |
COMMON STOCK | 0.001 | 0.005 |
(0.34) | (1.49) | |
REVENUES | −0.021 | −0.035 |
(−0.63) | (−1.14) | |
COS | −0.044 | −0.010 |
(−1.46) | (−0.35) | |
SGA | −0.012 | 0.015 |
(−1.02) | (1.22) | |
R&D | −0.247 *** | −0.198 *** |
(−4.55) | (−3.98) | |
CAPEX | −1.679 *** | −1.406 *** |
(−5.49) | (−4.53) | |
ADVERTISING | −0.341 | −0.283 |
(−1.59) | (−1.43) | |
NET INCOME | −0.013 | 0.014 |
(−1.15) | (1.15) | |
SPI | −0.003 | −0.034 ** |
(−0.23) | (−2.53) | |
CASH FLOWS | 0.058 *** | 0.036 *** |
(4.34) | (3.02) | |
TENURE | 0.029 *** | 0.023 *** |
(12.85) | (12.48) | |
BIG4 | 0.916 *** | 0.822 *** |
(29.32) | (28.37) | |
SPECIALIST | 0.065 * | 0.085 *** |
(1.71) | (2.60) | |
AUD OFFICE SIZE | 0.674 | 0.017 |
(0.48) | (0.01) | |
Observations | 11,498 | 11,498 |
Ind FE | YES | YES |
Pseudo R-squared | 0.140 | 0.134 |
(1) | (2) | (3) | |
---|---|---|---|
COVID REPORT | COVID REPORT | COVID REPORT | |
FAIR VALUE | GCO | HISTORICAL | |
CASH | −0.014 | 0.011 ** | −0.003 |
(−1.31) | (2.19) | (−1.26) | |
AR | −0.005 | 0.003 | −0.006 * |
(−0.32) | (0.49) | (−1.77) | |
INVENTORY | −0.011 | 0.011 | 0.004 |
(−0.54) | (1.17) | (0.73) | |
PPE | 0.002 | 0.019 *** | −0.001 |
(0.13) | (3.45) | (−0.26) | |
INTANGIBLE | 0.021 | 0.020 *** | −0.005 |
(1.24) | (2.59) | (−1.26) | |
GOODWILL | 0.031 ** | 0.016 ** | −0.002 |
(1.96) | (2.25) | (−0.62) | |
AP | 0.000 | 0.000 | 0.000 |
(0.67) | (0.47) | (0.07) | |
DEFERRED REV | −0.002 | −0.001 | −0.000 |
(−0.37) | (−0.32) | (−0.15) | |
DEBT | 0.000 | 0.000 | −0.000 |
(0.36) | (0.38) | (−0.04) | |
RETAINED EARNINGS | 0.000 | 0.000 | 0.000 |
(0.20) | (0.42) | (0.14) | |
DIVIDENDS | −0.001 | −0.005 *** | −0.000 |
(−0.24) | (−2.61) | (−0.10) | |
COMMON STOCK | 0.000 | 0.000 | −0.000 |
(0.32) | (0.36) | (−0.03) | |
REVENUES | −0.000 | 0.004 *** | −0.000 |
(−0.16) | (2.92) | (−0.23) | |
COS | −0.000 | 0.001 | 0.000 |
(−0.22) | (0.69) | (0.11) | |
SGA | 0.000 | 0.000 | 0.000 |
(0.17) | (0.14) | (0.03) | |
R&D | 0.000 | 0.000 | 0.000 |
(0.36) | (0.13) | (0.15) | |
CAPEX | −0.012 | −0.004 | −0.001 |
(−1.21) | (−0.85) | (−0.22) | |
ADVERTISING | −0.009 | −0.001 | −0.001 |
(−0.51) | (−0.14) | (−0.12) | |
NET INCOME | 0.000 | 0.000 | 0.000 |
(0.16) | (0.16) | (0.02) | |
SPI | 0.000 | 0.000 | 0.000 |
(0.08) | (0.30) | (0.06) | |
CASH FLOWS | 0.000 | −0.000 | 0.000 |
(0.53) | (−0.25) | (0.20) | |
TENURE | −0.000 | −0.000 | 0.000 |
(−0.07) | (−0.94) | (0.87) | |
BIG4 | 0.000 | −0.013 *** | 0.001 |
(0.11) | (−7.62) | (0.66) | |
SPECIALIST | 0.000 | 0.003 | −0.002 * |
(0.02) | (1.24) | (−1.83) | |
AUD OFFICE SIZE | 0.147 | 0.025 | −0.003 |
(0.82) | (0.31) | (−0.07) | |
CONSTANT | 0.029 *** | 0.001 | 0.004 * |
(3.40) | (0.26) | (1.73) | |
Observations | 11,497 | 11,497 | 11,497 |
Ind FE | YES | YES | YES |
Pseudo R-squared | 0.020 | 0.012 | 0.003 |
(1) | (2) | (3) | |
---|---|---|---|
(−3,−1) | (0,0) | (+1,+3) | |
CAR | Pre | Filing Day | Post |
COVID REPORT | 0.008 | 0.005 | 0.073 * |
(0.27) | (0.39) | (1.80) | |
Controls | YES | YES | YES |
Observations | 4464 | 4464 | 4464 |
Ind FE | YES | YES | YES |
Adjusted R-squared | 0.019 | 0.003 | 0.003 |
(1) | (2) | (3) | (4) | (5) | (6) | |
---|---|---|---|---|---|---|
AUDIT FEES | AUDIT FEES | AUDIT FEES | ABNORMAL AF | ABNORMAL AF | ABNORMAL AF | |
COVID REPORT | 0.172 *** | 0.081 *** | ||||
(5.05) | (2.73) | |||||
COVID REPORT—IMPAIRMENT | 0.256 *** | 0.131 *** | ||||
(5.01) | (2.93) | |||||
COVID REPORT—FV | 0.153 *** | 0.057 * | ||||
(4.02) | (1.73) | |||||
COVID REPORT—GCO | 0.305 *** | 0.205 *** | ||||
(3.63) | (2.80) | |||||
F-test: | ||||||
β2 = β3 | F = 2.75; | F = 3.41; | ||||
p = 0.10 | p = 0.06 | |||||
Controls | YES | YES | YES | YES | YES | YES |
Observations | 11,498 | 11,498 | 11,498 | 11,498 | 11,498 | 11,498 |
Ind FE | YES | YES | YES | YES | YES | YES |
Adjusted R-squared | 0.823 | 0.823 | 0.823 | 0.369 | 0.369 | 0.369 |
(1) | (2) | (3) | (4) | |
---|---|---|---|---|
ACCT ESTIMATE | SIG ACCT ESTIMATE | AUDIT FEES | ABNORMAL AF | |
COVID REPORT | 0.784 *** | 1.215 *** | 0.154 *** | 0.082 *** |
(56.18) | (57.23) | (14.34) | (8.57) | |
Accounting Estimate Controls | YES | YES | ||
Audit Fee Model Controls | YES | YES | ||
Observations | 11,498 | 11,498 | 11,498 | 11,498 |
Ind FE | YES | YES | YES | YES |
Pseudo/Adjusted R-squared | 0.374 | 0.378 | 0.875 | 0.368 |
(1) | (2) | (3) | (4) | ||
---|---|---|---|---|---|
1st Stage | 2nd Stage | ||||
COVID REPORT | ACCT ESTIMATE | SIG ACCT ESTIMATE | AUDIT FEES | ABNORMAL AF | |
COVID-RISK | 0.334 *** | ||||
(3.88) | |||||
COVID_RESIDUAL | 0.338 *** | 0.334 *** | 0.039 *** | 0.019 *** | |
(20.61) | (20.91) | (5.39) | (3.03) | ||
Determinants Model Controls | YES | ||||
Accounting Estimate Controls | YES | YES | |||
Audit Fee Model Controls | YES | YES | |||
Observations | 11,034 | 11,034 | 11,034 | 11,034 | 11,034 |
Ind FE | YES | YES | YES | YES | YES |
Adjusted / Pseudo R-squared | 0.215 | 0.146 | 0.138 | 0.818 | 0.080 |
(1) | (2) | (3) | (4) | (5) | |
---|---|---|---|---|---|
1st Stage | 2nd Stage | ||||
COVID REPORT | ACCT ESTIMATE | SIG ACCT ESTIMATE | AUDIT FEES | ABNORMAL AF | |
COVID CASES | 0.006 * | ||||
(1.67) | |||||
5.940 *** | 8.944 *** | 4.224 *** | 2.880 *** | ||
(3.93) | (3.96) | (3.34) | (2.69) | ||
Accounting Estimate Controls | YES | YES | |||
Audit Fee Model Controls | YES | YES | |||
Observations | 4780 | 4803 | 4803 | 4803 | 4803 |
State FE | YES | ||||
Ind FE | YES | YES | YES | YES | YES |
Pseudo/Adjusted R-squared | 0.054 | 0.219 | 0.222 | 0.828 | 0.350 |
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2025 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Micale, J.A.; Kong, J.H. COVID-19-Related Audit Report Disclosures: Determinants and Consequences. J. Risk Financial Manag. 2025, 18, 21. https://doi.org/10.3390/jrfm18010021
Micale JA, Kong JH. COVID-19-Related Audit Report Disclosures: Determinants and Consequences. Journal of Risk and Financial Management. 2025; 18(1):21. https://doi.org/10.3390/jrfm18010021
Chicago/Turabian StyleMicale, Joseph A., and Joon Ho Kong. 2025. "COVID-19-Related Audit Report Disclosures: Determinants and Consequences" Journal of Risk and Financial Management 18, no. 1: 21. https://doi.org/10.3390/jrfm18010021
APA StyleMicale, J. A., & Kong, J. H. (2025). COVID-19-Related Audit Report Disclosures: Determinants and Consequences. Journal of Risk and Financial Management, 18(1), 21. https://doi.org/10.3390/jrfm18010021